ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
16 Feb 2017 Press Release: ESMO Supports the 2017 WHO Cancer Resolution Bioethics, legal and economic issues
09 Feb 2017 Press Release: ESMO Announces New Award for Achievements in Immune-Oncology
09 Feb 2017 Media Alert: ESMO Summit Africa 2017
18 Jan 2017 Press Release: Biosimilars Create Opportunities for Sustainable Cancer Care Anticancer agents & Biologic therapy
21 Dec 2016 ESMO Asia 2016 Media Alert: ESMO Holds Second Successful Congress in Singapore
18 Dec 2016 ESMO Asia 2016 Press Release: Immunotherapy with Pembrolizumab Deemed Cost-Effective for Advanced Melanoma Patients in Hong Kong Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
18 Dec 2016 ESMO Asia 2016 Press Release: Routine Blood Test Predicts How Long Cancer Patients Will Survive Palliative and supportive care
18 Dec 2016 ESMO Asia 2016 Press Release: Cancer Costs Leaving Patients in Debt Bioethics, legal and economic issues
18 Dec 2016 ESMO Asia 2016 Press Release: Depressed Patients Are Less Responsive to Chemotherapy Anticancer agents & Biologic therapy
18 Dec 2016 ESMO Asia 2016 Press Release: Anxiety and Depression a Major Issue for Cancer Survivors
18 Dec 2016 ESMO Asia 2016 Press Release: Ribociclib Improves Progression-free Survival in Asian Women with Advanced Breast Cancer Breast cancer
17 Dec 2016 ESMO Asia 2016 Press Release: First Data on Rare Sarcomas in Asian Patients Presented at ESMO Asia in Singapore Sarcomas
15 Dec 2016 ESMO Asia 2016 Media Alert: ESMO Asia Congress to Return to Singapore for the 2nd Time
16 Dec 2016 ESMO Asia 2016 Press Release: Asian Head and Neck Cancer Patients Live Longer with Immunotherapy than Mixed Race Group Head and neck cancers
14 Dec 2016 ESMO Asia 2016 Press Release: Almost 20% of Breast Cancer Patients Fail to Complete Prescribed Endocrine Therapy Breast cancer